Search company, investor...

Predict your next investment

Venture Capital
fh-partners.com

Investments

44

Portfolio Exits

8

Funds

4

About Fountain Healthcare Partners

Headquartered in Dublin, Fountain Healthcare Partners is Ireland's largest dedicated life science venture capital fund. A spin-out investment team from Elan Corporation's corporate venture capital group, Fountain launched its inaugural fund in 2008. Fountainl invests the majority of its capital in Europe with a primary focus on Ireland. Specific areas of interest to Fountain are specialty pharmaceuticals, biotechnology, medical devices and diagnostics.

Headquarters Location

Guild House, 4th Floor Guild Street

Dublin, 1,

Ireland

+353 1 5225100

Want to inform investors similar to Fountain Healthcare Partners about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest Fountain Healthcare Partners News

Corteria Pharmaceuticals Raises €65M in Series A Funding

Sep 7, 2023

Corteria Pharmaceuticals, a Paris, France-based biopharmaceutical company specialized in the development of therapies for unaddressed heart failure subpopulations, raised €65M in Series A funding. The round was led by OrbiMed and Jeito Capital, with participation from existing seed investors Kurma Partners, Fountain Healthcare Partners, V-Bio Ventures, Invivo Capital, and Omnes Capital. As a result, Erez Chimovits from OrbiMed and Andreas Wallnoefer from Jeito Capital will join the board of Directors of Corteria. The company intends to use the funds to advance its cardiovascular pipeline into the clinic. Founded in 2021 by Philip Janiak and Marie-Laure Ozoux, Corteria Pharmaceuticals is advancing drugs in heart failure subpopulations. Since foundation, the company’s pipeline has expanded and now includes three first-in-class therapies that are highly differentiated as they produce multi-organ benefits, acting on the kidneys, the heart, and the vessels: A once daily subcutaneous CRF2 agonist for the treatment of Worsening Heart Failure A once monthly subcutaneous CRF2 agonist for the treatment of Right Heart Failure An AVP (arginine vasopressin) neutralizing monoclonal antibody for the treatment of Acute Heart Failure with Hyponatremia The lead asset for Worsening Heart Failure is expected to enter the clinic in early 2024. FinSMEs 07/09/2023

Fountain Healthcare Partners Investments

44 Investments

Fountain Healthcare Partners has made 44 investments. Their latest investment was in Corteria Pharmaceuticals as part of their Series A on September 9, 2023.

CBI Logo

Fountain Healthcare Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/7/2023

Series A

Corteria Pharmaceuticals

$71M

Yes

2

5/15/2023

Series A

Dualyx

$44M

Yes

9

7/20/2022

Series B

Medical Micro Instruments

$75M

No

4

6/30/2022

Series A - II

Subscribe to see more

$99M

Subscribe to see more

10

5/17/2022

Series D

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/7/2023

5/15/2023

7/20/2022

6/30/2022

5/17/2022

Round

Series A

Series A

Series B

Series A - II

Series D

Company

Corteria Pharmaceuticals

Dualyx

Medical Micro Instruments

Subscribe to see more

Subscribe to see more

Amount

$71M

$44M

$75M

$99M

$99M

New?

Yes

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

9

4

10

10

Fountain Healthcare Partners Portfolio Exits

8 Portfolio Exits

Fountain Healthcare Partners has 8 portfolio exits. Their latest portfolio exit was Syndesi Therapeutics on March 01, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

3/1/2022

Acquired

$99M

5

9/21/2020

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

8/11/2020

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

4/10/2017

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

3/7/2016

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

3/1/2022

9/21/2020

8/11/2020

4/10/2017

3/7/2016

Exit

Acquired

Acquired

Acquired

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

5

10

10

10

10

Fountain Healthcare Partners Fund History

4 Fund Histories

Fountain Healthcare Partners has 4 funds, including Fountain Healthcare Partners Fund III.

Closing Date

Fund

Fund Type

Status

Amount

Sources

11/3/2020

Fountain Healthcare Partners Fund III

$146.29M

2

12/31/2015

Fountain Healthcare Partners Fund II

Subscribe to see more

Subscribe to see more

$99M

10

1/9/2015

Fountain Healthcare Partners II

$99M

10

3/1/2008

Fountain Healthcare Partners I

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

11/3/2020

12/31/2015

1/9/2015

3/1/2008

Fund

Fountain Healthcare Partners Fund III

Fountain Healthcare Partners Fund II

Fountain Healthcare Partners II

Fountain Healthcare Partners I

Fund Type

Subscribe to see more

Subscribe to see more

Status

Subscribe to see more

Subscribe to see more

Amount

$146.29M

$99M

$99M

$99M

Sources

2

10

10

10

Fountain Healthcare Partners Team

3 Team Members

Fountain Healthcare Partners has 3 team members, including current Founder, Managing Partner, Aidan King.

Name

Work History

Title

Status

Aidan King

Founder, Managing Partner

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Aidan King

Subscribe to see more

Subscribe to see more

Work History

Title

Founder, Managing Partner

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.